BR112014011831A2 - copolímero em bloco tendo grupo ácido fenilborônico nele introduzido e o uso deste - Google Patents
copolímero em bloco tendo grupo ácido fenilborônico nele introduzido e o uso desteInfo
- Publication number
- BR112014011831A2 BR112014011831A2 BR112014011831A BR112014011831A BR112014011831A2 BR 112014011831 A2 BR112014011831 A2 BR 112014011831A2 BR 112014011831 A BR112014011831 A BR 112014011831A BR 112014011831 A BR112014011831 A BR 112014011831A BR 112014011831 A2 BR112014011831 A2 BR 112014011831A2
- Authority
- BR
- Brazil
- Prior art keywords
- block copolymer
- acid group
- phenylboronic acid
- drug
- group introduced
- Prior art date
Links
- 229920001400 block copolymer Polymers 0.000 title abstract 5
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical group OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
- A61K47/6455—Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/42—Polyamides containing atoms other than carbon, hydrogen, oxygen, and nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161561022P | 2011-11-17 | 2011-11-17 | |
| PCT/JP2012/079897 WO2013073697A1 (ja) | 2011-11-17 | 2012-11-19 | フェニルボロン酸基が導入されたブロックコポリマーおよびその使用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014011831A2 true BR112014011831A2 (pt) | 2017-05-09 |
Family
ID=48429749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014011831A BR112014011831A2 (pt) | 2011-11-17 | 2012-11-19 | copolímero em bloco tendo grupo ácido fenilborônico nele introduzido e o uso deste |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9114177B2 (enExample) |
| EP (1) | EP2781536B1 (enExample) |
| JP (1) | JP5481614B2 (enExample) |
| KR (1) | KR101912978B1 (enExample) |
| CN (1) | CN104093768B (enExample) |
| AU (1) | AU2012337721B2 (enExample) |
| BR (1) | BR112014011831A2 (enExample) |
| CA (1) | CA2853902A1 (enExample) |
| ES (1) | ES2603632T3 (enExample) |
| IN (1) | IN2014CN03580A (enExample) |
| MX (1) | MX2014005540A (enExample) |
| RU (1) | RU2014124333A (enExample) |
| WO (1) | WO2013073697A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2692777B1 (en) | 2011-03-31 | 2018-10-31 | NanoCarrier Co., Ltd. | Pharmaceutical composition containing block copolymer comprising boronic acid compound |
| JP6195171B2 (ja) | 2012-04-27 | 2017-09-13 | 国立大学法人 東京大学 | 核酸デリバリー用ユニット構造型医薬組成物 |
| WO2015121924A1 (ja) * | 2014-02-12 | 2015-08-20 | 一般社団法人医療産業イノベーション機構 | ｍＲＮＡ送達用組成物 |
| JP6566936B2 (ja) * | 2014-05-08 | 2019-08-28 | 国立大学法人 東京大学 | 医薬組成物 |
| KR101891655B1 (ko) * | 2016-05-17 | 2018-08-24 | 기초과학연구원 | 페닐보론산이 결합된 고분자를 포함하는 약물 전달체 |
| JPWO2018025699A1 (ja) * | 2016-08-02 | 2019-05-30 | 日本化薬株式会社 | アクティブターゲティング型高分子誘導体、その高分子誘導体を含む組成物、及びそれらの用途 |
| EP3501544B1 (en) * | 2016-08-22 | 2021-07-28 | Tokyo Institute of Technology | Ligand capable of multivalently binding to glutamine transporter, and composition comprising same |
| CN111050752B (zh) * | 2017-08-31 | 2022-08-16 | 国立大学法人东京大学 | 搭载核酸的单元型聚离子复合物 |
| KR102075476B1 (ko) * | 2017-12-29 | 2020-02-10 | 포항공과대학교 산학협력단 | 페닐보론산이 결합된 고분자를 포함하는 하이드로겔 |
| CN121136065A (zh) | 2018-04-27 | 2025-12-16 | 基因编辑有限公司 | 阳离子聚合物和用于生物分子递送的用途 |
| JP2022502384A (ja) | 2018-09-25 | 2022-01-11 | 国立大学法人 東京大学 | 両親媒性ポリアミノ酸、該両親媒性ポリアミノ酸を用いたブロックコポリマー、および該両親媒性ポリアミノ酸または該ブロックコポリマーと核酸とを含む複合体 |
| WO2020241819A1 (ja) | 2019-05-29 | 2020-12-03 | 国立大学法人東京工業大学 | 複合体、医薬、癌治療剤、キット及び結合体 |
| AU2020348451A1 (en) | 2019-09-20 | 2022-04-21 | Glyscend, Inc. | Substituted phenyl boronic acid containing polymers and methods of use |
| JP7739406B2 (ja) * | 2021-03-10 | 2025-09-16 | Ａｇｃ株式会社 | 含ハロゲン部位を有するポリマーおよび該ポリマーを用いた医薬組成物 |
| CN114163591B (zh) * | 2021-11-29 | 2023-08-01 | 南方医科大学 | 一种嵌段共聚物、嵌段共聚物载药胶束及其制备方法和应用 |
| CN114533669B (zh) | 2022-01-18 | 2022-11-04 | 武汉大学 | 一种口腔护理组合物及其制备方法和应用 |
| CN114632145B (zh) * | 2022-03-07 | 2024-02-27 | 浙江大学 | 一种负载胰岛素的苯硼酸/脂肪酸双改性ε-聚赖氨酸颗粒及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3257029B2 (ja) * | 1992-04-22 | 2002-02-18 | 日本油脂株式会社 | フェニルボロン酸誘導体及び製造方法 |
| JPH083172A (ja) * | 1994-06-15 | 1996-01-09 | Nippon Oil & Fats Co Ltd | フェニルボロン酸誘導体および製造方法 |
| US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| JP2002179683A (ja) * | 2000-12-13 | 2002-06-26 | Japan Science & Technology Corp | ポリアミノ酸誘導体から成る核酸関連物質反応試薬 |
| CA2666697C (en) | 2006-10-19 | 2015-03-31 | Nanocarrier Co., Ltd. | Block copolymer for drug conjugates and pharmaceutical composition |
| JP2010519305A (ja) | 2007-02-26 | 2010-06-03 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | 併用薬物送達のためのポリマー性ミセル |
| WO2009133647A1 (ja) | 2008-05-02 | 2009-11-05 | 国立大学法人筑波大学 | 高分子化環状二トロキシドラジカル化合物およびその使用 |
| EP2296708A4 (en) | 2008-05-13 | 2011-10-26 | Univ Washington | POLYMER CARRIER |
| AU2009277456B2 (en) | 2008-07-29 | 2011-05-26 | Nanocarrier Co., Ltd. | Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| WO2010019718A2 (en) | 2008-08-13 | 2010-02-18 | California Institute Of Technology | Carrier nanoparticles and related compositions, methods and systems |
| WO2010114770A1 (en) | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| JP5622188B2 (ja) * | 2010-01-05 | 2014-11-12 | 独立行政法人物質・材料研究機構 | フェニルボロン酸系単量体及びフェニルボロン酸系重合体 |
| JP2011173960A (ja) | 2010-02-23 | 2011-09-08 | Univ Of Tsukuba | 高分子ミセル型光刺激応答性一酸化窒素供与体 |
| EP2692777B1 (en) | 2011-03-31 | 2018-10-31 | NanoCarrier Co., Ltd. | Pharmaceutical composition containing block copolymer comprising boronic acid compound |
-
2012
- 2012-11-19 WO PCT/JP2012/079897 patent/WO2013073697A1/ja not_active Ceased
- 2012-11-19 CN CN201280056639.0A patent/CN104093768B/zh not_active Expired - Fee Related
- 2012-11-19 RU RU2014124333/04A patent/RU2014124333A/ru not_active Application Discontinuation
- 2012-11-19 CA CA2853902A patent/CA2853902A1/en not_active Abandoned
- 2012-11-19 KR KR1020147013186A patent/KR101912978B1/ko not_active Expired - Fee Related
- 2012-11-19 MX MX2014005540A patent/MX2014005540A/es unknown
- 2012-11-19 EP EP12850688.8A patent/EP2781536B1/en not_active Not-in-force
- 2012-11-19 ES ES12850688.8T patent/ES2603632T3/es active Active
- 2012-11-19 AU AU2012337721A patent/AU2012337721B2/en not_active Ceased
- 2012-11-19 US US14/358,816 patent/US9114177B2/en not_active Expired - Fee Related
- 2012-11-19 JP JP2013529476A patent/JP5481614B2/ja not_active Expired - Fee Related
- 2012-11-19 BR BR112014011831A patent/BR112014011831A2/pt not_active IP Right Cessation
- 2012-11-19 IN IN3580CHN2014 patent/IN2014CN03580A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2781536A4 (en) | 2015-06-10 |
| MX2014005540A (es) | 2014-09-22 |
| KR20140106511A (ko) | 2014-09-03 |
| CN104093768A (zh) | 2014-10-08 |
| AU2012337721B2 (en) | 2015-12-10 |
| CN104093768B (zh) | 2016-09-21 |
| IN2014CN03580A (enExample) | 2015-10-09 |
| JPWO2013073697A1 (ja) | 2015-04-02 |
| CA2853902A1 (en) | 2013-05-23 |
| US20150051347A1 (en) | 2015-02-19 |
| EP2781536B1 (en) | 2016-08-17 |
| JP5481614B2 (ja) | 2014-04-23 |
| AU2012337721A1 (en) | 2014-05-22 |
| EP2781536A1 (en) | 2014-09-24 |
| KR101912978B1 (ko) | 2018-10-29 |
| RU2014124333A (ru) | 2015-12-27 |
| WO2013073697A1 (ja) | 2013-05-23 |
| ES2603632T3 (es) | 2017-02-28 |
| US9114177B2 (en) | 2015-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014011831A2 (pt) | copolímero em bloco tendo grupo ácido fenilborônico nele introduzido e o uso deste | |
| CY1119766T1 (el) | Νεοι ρυθμιστες κινασης βενζοπυρανιου | |
| CY1118452T1 (el) | Ενωσεις και συνθεσεις ως αναστολεις πρωτεϊνικης κινασης | |
| BRPI0908421C1 (pt) | solução estável de um composto farmacêutico | |
| CY1121170T1 (el) | Νεες ενωσεις ως ρυθμιστες πρωτεϊνικων κινασων | |
| EA201070421A1 (ru) | Микрорибонуклеиновые кислоты | |
| CY1117869T1 (el) | Φαρμακοτεχνικες μορφες για απο του στοματος απελευθερωση προσροφητικων στο εντερο | |
| ECSP099426A (es) | Compuestos de 4-hidroxi-2-oxo-2,3-dihidro-1,3-benzotiazol-7il para la modulación de la actividad del adrenoreceptor beta2 | |
| EA201200174A1 (ru) | Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений | |
| EA201370008A1 (ru) | Лечение когнитивных нарушений | |
| EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
| HK1206362A1 (zh) | 硫代氨基磷酸酯核苷酸前藥的固體形式 | |
| EA201270803A1 (ru) | Тиоацетатные соединения, композиции на их основе и способы их применения | |
| EA202091999A2 (ru) | Применение ингибиторов dpp iv | |
| EA201200952A1 (ru) | Производные пиразина и их применение для лечения неврологических нарушений | |
| EA201390821A1 (ru) | Антагонисты рецепторов лизофосфатидной кислоты и их применение | |
| BR112014016338A8 (pt) | polímeros de polioxazolina e processos para a sua preparação, conjugados destes polímeros e usos médicos dos mesmos | |
| BR112014019776A2 (pt) | composições e métodos para o tratamento de doença vascular periférica | |
| CL2014000210A1 (es) | Una composicion de prodroga que comprende al menos un conjugado de metilfenidato; kit farmaceutico que la comprende, util para el tratamiento de una enfermedad o condicion que requiere estimulacion del sistema nervioso tal como un trastorno de hiperactividad con deficit de atencion y depresion. | |
| BR112013029256A2 (pt) | "combinações farmacêuticas para uso no tratamento de pacientes com diabetes tipo 2, método de tratamento, e usos de lixisenatida e metformina". | |
| BR112014031372A2 (pt) | implantes/procedimentos relacionados ao avanço da tuberosidade tibial | |
| BR112012026724A2 (pt) | combinação de fármcos com pró-fármacos ligados à proteína | |
| BR112013004016A2 (pt) | formulações á base de nalbufina e as respectivas utilizações | |
| UY33276A (es) | Compuestos de amino-oxazinas y amino-dihidrotiazina como moduladores de beta-secretasa y métodos de uso | |
| BR112013004850A2 (pt) | tratamento de infarto do miocárdio usando antagonistas tgf-beta |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B25H | Request for change of headquarter rejected |
Owner name: THE UNIVERSITY OF TOKYO (JP) , NATIONAL UNIVERSITY |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |